Trabecular Meshwork Stem Cell Secretome for Treatment of Glaucoma05099Stem cell secretome from trabecular meshwork lowers intraocular pressure, preserves vision via non-invasive, scalable glaucoma treatment.Technology TypeTherapeutic ModalityTechnology SubtypeProteinTherapeutic AreasOphthalmologyTherapeutic IndicationsGlaucomaLead InventorYiqin DuDepartmentDepartment of OphthalmologyAll Tech InnovatorsYiqin DuAjay KumarTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2019-08-27CollectionsRegenerative Medicine
Automated 3D OCT Vessel Segmentation Framework for Precise Retinal Blood Vessel Mapping01998Automated 3D SD-OCT vessel segmentation fuses 2D fundus and 3D OCT cues for robust retinal vessel mapping and early disease detection.Technology TypeMedical DeviceTechnology SubtypeDiagnostic ImagingTherapeutic AreasOphthalmologyTherapeutic IndicationsGlaucomaTagsMicroscopyLead InventorJuan XuDepartmentMed-OphthalmologyAll Tech InnovatorsHiroshi IshikawaJoel Steven SchumanDavid TolliverDate Submitted2009-05-11
Dipeptidyl Peptidase-4 (DPP4) Inhibitors for Inhibiting Posterior Capsular Opacification07055DPP4 inhibitors delivered locally prevent posterior capsular opacification by blocking TGF-β–driven EMT in lens cells.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasOphthalmologyTherapeutic IndicationsCataractsTagsAgingDrug RepurposingLead InventorKun Che ChangDepartmentMed-OphthalmologyAll Tech InnovatorsKun Che ChangChi-Yu ChenPei-Kang LiuTechnology Readiness Level4. Pre-clinical developmentDate Submitted2025-01-31CollectionsRegenerative Medicine
Automated OCT-Based Tissue Screening System06669Automated OCT tissue screening with deep learning for label-free, high-throughput, quantitative 3-D tissue analysis and drug screening.Technology TypeLife Science Research ToolTechnology SubtypeOther Life Science Research ToolTherapeutic AreasOphthalmologyTagsMicroscopyMachine learningPlatform TechnologyLead InventorShaohua PiDepartmentMed-OphthalmologyAll Tech InnovatorsYuanyuan ChenShaohua PiJose Alain SahelTechnology Readiness Level4. Prototype testing and refinementDate Submitted2024-03-06
Novel Repair and Regeneration Therapy for Glaucoma07246AAV-Ina overexpression promotes retinal ganglion cell survival and axon regeneration, offering neuroprotection for glaucoma with regeneration potential.Technology TypeTherapeutic ModalityTherapeutic AreasOphthalmologyNeuroscienceTherapeutic IndicationsGlaucomaTagsDrug Discovery - TargetLife ScienceLead InventorKun Che ChangDepartmentMed-OphthalmologyAll Tech InnovatorsKun Che ChangChi-Yu ChenDate Submitted2025-07-11
Plasmin-Enhanced Transplantation of Retinal Ganglion Cells via Internal Limiting Membrane Digestion07056Plasmin digests the retinal ILM to improve donor retinal ganglion cell transplantation, boosting survival without inflammation.Technology TypeLife Science Research ToolTechnology SubtypeProteinTherapeutic AreasOphthalmologyTherapeutic IndicationsOtherLead InventorKun Che ChangDepartmentMed-OphthalmologyAll Tech InnovatorsKun Che ChangDimitrios StavropoulosDate Submitted2025-01-31
Anti-Inflammatory Biotherapeutics for Eye Wound06908Engineered eye bacteria deliver IL-10 to corneal wounds, accelerating healing with a novel, low-maintenance ocular therapy.Technology TypeTherapeutic ModalityTechnology SubtypeProteinTherapeutic AreasOphthalmologyTherapeutic IndicationsOcular hypertensionTagsLife ScienceLead InventorAnthony St LegerDepartmentMed-OphthalmologyAll Tech InnovatorsJackie Lynn ShaneAnthony J. St LegerDate Submitted2024-09-30CollectionsRegenerative Medicine
Walk-N-Talk: An Accessible Speech Generation Device06715Walk-N-Talk attaches to canes to provide preprogrammed speech prompts for nonverbal, visually impaired users.Technology TypeMedical DeviceTechnology SubtypeRehab or Assistive Medical DeviceTherapeutic AreasOphthalmologyLead InventorBrad DiciannoDepartmentMed-Physical Medicine & RehabilitationAll Tech InnovatorsBrad E. DiciannoLisa Swanson DoveOwen FlaughDate Submitted2024-04-12
Novel Treatment for Retinitis Pigmentosa06383Pyrvinium targets NS LLPS to restore proteostasis, preserve retinal structure, and may treat retinitis pigmentosa and proteinopathies.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasOphthalmologyNeuroscienceTherapeutic IndicationsParkinson's DiseaseAlzheimer's DiseaseRetinitis pigmentosa (RP)TagsLife ScienceLead InventorBokai ZhuDepartmentMed-MedicineAll Tech InnovatorsYuanyuan ChenWilliam A. DionBokai ZhuDate Submitted2023-04-23
CyteSolutions Lens: Drug-Eluting Contact Lens Technology04712CyteSolutions Lens enables days-long, low-dose, sustained drug delivery via a smart contact lens to treat dry eye inflammation.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasOphthalmologyLead InventorAlexis NolfiDepartmentOffice of the SVC and ProvostAll Tech InnovatorsBryan Nicklaus BrownVishal JhanjiAlexis Lauren NolfiTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2018-08-17
SWeeTT: Solitary Wave-based easily-employable Trans-palpebral Tonometer04573SWeeTT enables easy, at-home, trans-palpebral intraocular pressure monitoring with daily data and clinician connectivity.Technology TypeDiagnostic/AssayTechnology SubtypeOther Diagnostic/AssayTherapeutic AreasOphthalmologyLead InventorPiervincenzo RizzoDepartmentCivil & Environmental EngineeringAll Tech InnovatorsAmir NasrollahiPiervincenzo RizzoDate Submitted2018-03-31
Prevention of DED Utilizing a Histone/Protein Deacetylase Inhibitor (HDACi)04403HDAC inhibitor-loaded PLGA microspheres deliver targeted, long-term anti-inflammatory therapy for dry eye by boosting regulatory T cells.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasOphthalmologyTherapeutic IndicationsConjunctivitisDry eye syndromeUveitic macular edema (UME)Lead InventorSteven LittleDepartmentEngr-Dept Chairperson's OfficeAll Tech InnovatorsSteven R. LittleMichelle Lynn RatayTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2017-10-09
Comparing OCT Scans from Baseline and Follow Up06320New OCT/OCTA 3D change-mapping algorithm compares baseline vs. follow-up scans without layer segmentation, enabling earlier retinal disease insight.Technology TypeMedical DeviceTechnology SubtypeDiagnostic ImagingTherapeutic AreasOphthalmologyLead InventorShaohua PiDepartmentMed-OphthalmologyAll Tech InnovatorsShaohua PiBingjie WangDate Submitted2023-02-28
Novel Treatment for Eye Disorders05703Monoclonal antibody blocks Lipocalin-2 to curb retinal inflammation and dry AMD progression, offering a preventive therapy.Technology TypeTherapeutic ModalityTechnology SubtypeAntibody - mAbTherapeutic AreasOphthalmologyNeuroscienceTherapeutic IndicationsStargardt DiseaseDiabetic retinopathyAge-related macular degenerationLead InventorDebasish SinhaDepartmentDepartment of OphthalmologyAll Tech InnovatorsSayan GhoshUrvi GuptaStacey HoseTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2021-05-26
Deep Learning System for Noise-Free Optical Coherence Tomography (OCT) Imaging without Clean Training Data06607Dual-scan, noise-free OCT denoising via Sub2Full: train on two noisy scans to reveal fine retinal structures without clean data.Technology TypeDigital HealthTechnology SubtypeHealthcare DataTherapeutic AreasOphthalmologyTherapeutic IndicationsDiabetic retinopathyTagsArtificial intelligence (AI)MicroscopyMachine learningLead InventorShaohua PiDepartmentMed-OphthalmologyAll Tech InnovatorsShaohua PiLingyun WangTechnology Readiness Level5. Advanced prototype validationDate Submitted2024-01-10CollectionsHealthcare AI
Profilin1-actin Interaction Inhibitor as a Novel Anti-Angiogenic Compound05290Profilin1–actin interaction inhibitor blocks ccRCC angiogenesis, offering a resistance-evading, low-toxicity anti-angiogenic cancer therapy.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasOphthalmologyOncologyTherapeutic IndicationsDiabetic retinopathyAge-related macular degenerationTagsPlatform TechnologyLead InventorPartha RoyDepartmentBioengineeringAll Tech InnovatorsPaul G. FrancoeurDavid Martin GauAbigail GondringerTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2020-04-09
Novel Glaucomatous Damage Prediction Tool07016AI-powered glaucoma risk predictor uses OCT to assess mechanical nonlinearity and RNFL changes for early intervention. 118 characters.Technology TypeDigital HealthTechnology SubtypeClinical Decision SupportTherapeutic AreasOphthalmologyTherapeutic IndicationsGlaucomaLead InventorTimothy ChungAll Tech InnovatorsTimothy K. ChungJohn DaniasJonathan P. Vande GeestDate Submitted2024-12-26CollectionsHealthcare AI
Use of Stem Cell Secretome to Prevent Corneal Scarring05943CSSC secretome enables scarless corneal healing, dampening inflammation, preserving nerves, reducing transplant needs.Technology TypeTherapeutic ModalityTechnology SubtypeProteinTherapeutic AreasOphthalmologyTherapeutic IndicationsOtherLead InventorYiqin DuDepartmentDepartment of OphthalmologyAll Tech InnovatorsYiqin DuAjay KumarYunshu LiTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2022-01-20CollectionsRegenerative Medicine
TriaGel: Comprehensive Gel Eye Dressing to Revolutionize Ocular First Aid04068TriaGel: a rapid, injectable ocular gel that stabilizes injuries, delivers anti-inflammatories, reduces complications and costs.Technology TypeEngineering TechnologyTechnology SubtypeIndustrial BiotechTherapeutic AreasOphthalmologyIntensive CareTagsRegenerative medicineMaterial ScienceLead InventorMorgan DileoDepartmentMed-OphthalmologyAll Tech InnovatorsMorgan Virginia DileoJenny YuDate Submitted2016-11-07CollectionsRegenerative Medicine
Novel Treatment for Posterior Capsulation06621GDF-15 blocks EMT to prevent posterior capsular opacification, potentially reducing recurrent surgeries and vision loss.Technology TypeTherapeutic ModalityTechnology SubtypeProteinTherapeutic AreasOphthalmologyTherapeutic IndicationsCataractsLead InventorKun Che ChangDepartmentMed-OphthalmologyAll Tech InnovatorsKun Che ChangChi-Yu ChenShining WangTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2024-01-31CollectionsRegenerative Medicine
Slow Drug Release for Ophthalmic Treatments05610Coacervate gel delivers CXCL10p peptide to the eye for slow, tunable dry eye treatment, reducing goblet cell loss.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasOphthalmologyTherapeutic IndicationsDry eye syndromeTagsLife ScienceLead InventorAlan WellsDepartmentMed-PathologyAll Tech InnovatorsShivalingappa Kottur SwamynathanYadong WangAlan H. WellsDate Submitted2021-02-08
Novel Methods for Treating Glaucoma06441Laser-irradiation photomodulates ocular tissue mechanics to stiffen or soften sclera, boosting glaucoma resilience without viruses.Technology TypeTherapeutic ModalityTechnology SubtypeOther Therapeutic ModalityTherapeutic AreasOphthalmologyTherapeutic IndicationsGlaucomaLead InventorIan SigalDepartmentMed-OphthalmologyAll Tech InnovatorsPo-Yi LeeIan Alejandro SigalTechnology Readiness Level2. Initial proof of concept, in-vitroDate Submitted2023-06-27
Noninvasive & Long-Acting Thermoresponsive Hydrogel for Sustained Ocular Drug Delivery02867Noninvasive, thermoresponsive ocular gel with drug-loaded microparticles enables month-long, drop-free sustained eye treatment.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasOphthalmologyTherapeutic IndicationsOtherGlaucomaDry eye syndromeLead InventorMorgan DileoDepartmentMed-OphthalmologyAll Tech InnovatorsAnthony CuginiMorgan Virginia DileoSteven R. LittleTechnology Readiness Level4. Pre-clinical developmentDate Submitted2012-08-14
Novel Hepatocyte Growth Factor Receptor Agonist05468A humanized MET agonist META4 restores HGF-MET signaling, promoting tissue regeneration and potential therapies for liver disease and AMD.Technology TypeTherapeutic ModalityTechnology SubtypeAntibody - mAbTherapeutic AreasOphthalmologyHepatologyTherapeutic IndicationsOtherNon-alcoholic steatohepatitis (NASH)Diabetic retinopathyTagsRegenerative medicineLead InventorAbdolreza ZarnegarDepartmentMed-PathologyAll Tech InnovatorsAbdolreza ZarnegarTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2020-08-05CollectionsRegenerative MedicineCardiometabolic
Personalized Assembloids as AMD Models06978Patient-specific 3D retinal assembloid models AMD by combining hiPSC-derived PR/RPE with biomimetic Bruch’s membrane and vasculature.Technology TypeLife Science Research ToolTherapeutic AreasOphthalmologyTherapeutic IndicationsAge-related macular degenerationTagsLife ScienceLead InventorJonathan Vande GeestDepartmentBioengineeringAll Tech InnovatorsJay Kumar ChhablaniJincy JoySusana Isabel Morgado Mendes Antunes da>VFDate Submitted2024-11-15
High-Precision Vision Restoration Using Soma-Targeted Optogenetics06357Soma-targeted opsins enable single-cell-resolution retinal activation, improving high-acuity vision with reduced cross-activation for restoration.Technology TypeTherapeutic ModalityTechnology SubtypeProteinTherapeutic AreasOphthalmologyTherapeutic IndicationsRetinitis pigmentosa (RP)Diabetic retinopathyAge-related macular degenerationLead InventorOr ShemeshDepartmentMed-OphthalmologyAll Tech InnovatorsPururav RamakrishnaOr ShemeshDate Submitted2023-03-21
Optimizing Corneal Stem Cell Therapy: Quality Screening for Enhanced Regenerative Outcomes06002Quality-controlled corneal stem cells selected by regenerative indicators enhance healing potential and consistency in scar treatment.Technology TypeTherapeutic ModalityTechnology SubtypeCell Therapy - Stem CellTherapeutic AreasOphthalmologyLead InventorHin-Fai YamDepartmentMed-OphthalmologyAll Tech InnovatorsIsabelle BilligDeepinder K. Dhaliwal M.D.Yiqin DuTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2022-04-13CollectionsCell & Gene TherapyRegenerative Medicine
Optical Coherence Tomography (OCT) Image Enhancement03534Virtual averaging accelerates OCT scanning by 80%, producing frame-averaged-quality images from rapid, nonframe-averaged data.Technology TypeMedical DeviceTechnology SubtypeDiagnostic ImagingTherapeutic AreasOphthalmologyLead InventorHiroshi IshikawaDepartmentMed-OphthalmologyAll Tech InnovatorsChieh-Li ChenHiroshi IshikawaJoel Steven SchumanDate Submitted2015-03-04
Image Registration for the Analysis of Fixational Eye Movement05074Synthetic-reference registration extracts fine-scale fixational eye movements from noisy, artifacted SLO frames for robust high-resolution diagnostics.Technology TypeDiagnostic/AssayTechnology SubtypeOther Diagnostic/AssayTherapeutic AreasOphthalmologyLead InventorEthan RossiDepartmentMed-OphthalmologyAll Tech InnovatorsEthan A. RossiMin ZhangDate Submitted2019-08-02
Signal Normalization Among Multiple Optical Coherence Tomography Devices03384Device-independent OCT normalization standardizes cross-device images via resampling, denoising, histogram-based scaling for consistent comparisons.Technology TypeMedical DeviceTechnology SubtypeDiagnostic ImagingTherapeutic AreasOphthalmologyTherapeutic IndicationsGlaucomaLead InventorChieh-Li ChenDepartmentBioengineeringAll Tech InnovatorsChieh-Li ChenHiroshi IshikawaJoel Steven SchumanDate Submitted2014-08-18
Novel Treatment for Dry Eye Disease05988IL-4 eye drops target inflammation and goblet cell dysfunction in dry eye disease, aiming for lasting tear film stability.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasOphthalmologyImmunologyTagsBiomaterialLead InventorAlexis NolfiDepartmentOffice of the SVC and ProvostAll Tech InnovatorsBryan Nicklaus BrownVishal JhanjiMangesh KulkarniTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2022-03-18
Small-Molecule Stabilizers of TFEB for Local Ocular Delivery in Age-Related Retinal Disease04690Small-molecule GT300 activates TFEB via intravitreal delivery, boosting retinal lysosome autophagy to modulate dry AMD.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasOphthalmologyTherapeutic IndicationsGlaucomaGeographic atrophyAge-related macular degenerationLead InventorBeibei ChenDepartmentMed-MedicineAll Tech InnovatorsBeibei ChenToren FinkelYuan LiuTechnology Readiness Level4. Pre-clinical developmentDate Submitted2018-07-26
Delivery of Biological Drugs to Epithelia04508Anchoring domains bind wet epithelia to prevent washout, enabling extended delivery of biologics to eyes, lungs, and mucosal tissues.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasOphthalmologyRespiratoryTherapeutic IndicationsChronic Obstructive Pulmonary Disease (COPD)AsthmaDry eye syndromeLead InventorRobert ShanksDepartmentMed-OphthalmologyAll Tech InnovatorsJes K. KlarlundRobert Michael Queen ShanksTechnology Readiness Level2. Initial proof of concept, in-vitroDate Submitted2018-02-15CollectionsWomen's & Reproductive Health
Non-contact OCT Imaging and Analysis System for 3D Visualization and Monitoring of Limbal Palisades02412Non-contact 3D OCT maps Palisades of Vogt for limbal stem cell niche profiling, disease monitoring, and donor assessment.Technology TypeMedical DeviceTechnology SubtypeDiagnostic ImagingTherapeutic AreasOphthalmologyLead InventorKira LathropDepartmentMed-OphthalmologyAll Tech InnovatorsLawrence E. Kagemann JrKira L. LathropJoel Steven SchumanDate Submitted2011-02-22
Innovative Screening Device for Early Detection of Retinal Ischemia in Diabetics00900A non-invasive pupillography device quantitatively detects retinal ischemia in diabetics, enabling quick primary-care screening and monitoring.Technology TypeDiagnostic/AssayTechnology SubtypeOther Diagnostic/AssayTherapeutic AreasOphthalmologyTherapeutic IndicationsDiabetic retinopathyLead InventorMichael GorinDepartmentMed-OphthalmologyAll Tech InnovatorsMichael B. GorinDate Submitted2004-01-22
A Novel Method of Visualizing Three-Dimensional Image Datasets01481New 3D imaging visualization adapts to tissue curvature, reducing artifacts across MRI, CT, ultrasound, and OCT for accurate clinical insight.Technology TypeDigital HealthTechnology SubtypeHealthcare DataTherapeutic AreasOphthalmologyLead InventorHiroshi IshikawaDepartmentMed-OphthalmologyAll Tech InnovatorsHiroshi IshikawaJoel Steven SchumanDate Submitted2007-04-16
Real-time Presentation Access Technology for the Blind04020Real-time, cloud-synced accessible PowerPoint slides for the blind via auto-presenter add-in, pub/sub, multi-device terminals.Technology TypeDigital HealthTechnology SubtypeHealthcare DeliveryTherapeutic AreasOphthalmologyLead InventorHyun KaDepartmentSHRS-Rehab Sci & TechAll Tech InnovatorsHyun Wook KaDate Submitted2016-09-03
Novel Autologus Serum Insert for Dry Eye Disease06434Autologous serum ocular insert stabilizes, daily-delivery dry eye treatment; longer shelf-life, fewer administrations than eyedrops.Technology TypeMedical DeviceTherapeutic AreasOphthalmologyTherapeutic IndicationsDry eye syndromeLead InventorMorgan DileoDepartmentMed-OphthalmologyAll Tech InnovatorsMorgan Virginia DileoVishal JhanjiTechnology Readiness Level3. Prototype developmentDate Submitted2023-06-19
Reverse Thermal Gels for Ocular Drug Delivery02138Thermo-responsive, biodegradable reverse-thermal gel self-assembles at body temperature for targeted ocular drug delivery and tissue engineering.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasOphthalmologyLead InventorDaewon ParkDepartmentBioengineeringAll Tech InnovatorsThomas R. Friberg M.S.,M.D.Daewon ParkYadong WangDate Submitted2010-01-21CollectionsRegenerative Medicine
Biomimetic Drug Delivery of an Immunomodulatory Agent for the Treatment of Dry Eye Disease03658Biomimetic, controlled-release immunomodulatory microspheres recruit Tregs to treat inflammatory eye diseases at the source with safer, longer relief.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasOphthalmologyTherapeutic IndicationsDry eye syndromeLead InventorMichelle RatayDepartmentBioengineeringAll Tech InnovatorsStephen C. BalmertMorgan Virginia DileoAndrew Jason GlowackiDate Submitted2015-06-22
Automated SD-OCT Optic Nerve Head Assessment System for Disc and Cup Segmentation and Glaucoma Classification01627Automated SD-OCT ONH system segments disc/cup, quantifies metrics, and classifies glaucoma via a trained shape model.Technology TypeDigital HealthTechnology SubtypeClinical Decision SupportTherapeutic AreasOphthalmologyTherapeutic IndicationsGlaucomaLead InventorHiroshi IshikawaDepartmentMed-OphthalmologyAll Tech InnovatorsHiroshi IshikawaJoel Steven SchumanChaim-Gadi WollsteinDate Submitted2008-01-17
New Gene Therapy Concept Shows Promise in Treating Age-Related Macular Degeneration05088AAV2 TFEB therapy rejuvenates retinal cells, delaying dry AMD progression and potentially aiding other neurodegenerative diseases.Technology TypeTherapeutic ModalityTechnology SubtypeGene Therapy - AAVTherapeutic AreasOphthalmologyTherapeutic IndicationsOtherAge-related macular degenerationLead InventorDebasish SinhaDepartmentDepartment of OphthalmologyAll Tech InnovatorsLeah Caroline Thomas ByrneSayan GhoshStacey HoseTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2019-08-09CollectionsCell & Gene Therapy
Using Trabecular Meshwork Stem Cells to Treat Glaucoma02257TM stem cell therapy rebuilds trabecular meshwork to normalize intraocular pressure, potentially slowing glaucoma progression.Technology TypeTherapeutic ModalityTechnology SubtypeCell Therapy - Stem CellTherapeutic AreasOphthalmologyTherapeutic IndicationsGlaucomaLead InventorYiqin DuDepartmentDepartment of OphthalmologyAll Tech InnovatorsYiqin DuJames L. FunderburghJoel Steven SchumanTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2010-06-30CollectionsCell & Gene Therapy
Portable Head-mounted Eye-tracking Device During Dizziness Episodes01647Portable, eye-tracking goggles with home dizziness monitoring, 60Hz infrared tracking, synchronized sensors, wireless data sharing for remote diagnosis.Technology TypeMedical DeviceTechnology SubtypeMonitoring Medical DeviceTherapeutic AreasOphthalmologyTagsConsumerLead InventorJoseph FurmanDepartmentMed-OtolaryngologyAll Tech InnovatorsJoseph M. FurmanMark S. RedfernDate Submitted2008-02-18
Topical Ethyl Pyruvate for Eye Scar Prevention01536Ethyl pyruvate as a safe, topical anti-scarring treatment for corneal injuries and post-surgery healing.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasOphthalmologyDermatologyLead InventorNirmala Sundar RajDepartmentMed-OphthalmologyAll Tech InnovatorsJames L. FunderburghJoel Steven SchumanNirmala Sundar RajTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2007-07-17CollectionsRegenerative Medicine
Susceptibility Genes for Age-Related Maculopathy (ARM) on Chromosome 10q2601066Identifies ARM risk via PLEKHA1 and LOC387715 variations on chromosome 10q26; enables predictive assays and arrays.Technology TypeDiagnostic/AssayTechnology SubtypeBiomarkerTherapeutic AreasOphthalmologyTherapeutic IndicationsAge-related macular degenerationLead InventorMichael GorinDepartmentMed-OphthalmologyAll Tech InnovatorsYvette Perry ConleyRobert E. Ferrell Ph.D.Michael B. GorinDate Submitted2005-03-15
Cross-dimensional OCT Registration for Aligning 2D Scans with 3D Volumes across Devices01633Cross-Device OCT alignment enables 2D-3D registration across time and platforms, preserving history and reducing variability.Technology TypeMedical DeviceTechnology SubtypeDiagnostic ImagingTherapeutic AreasOphthalmologyLead InventorHiroshi IshikawaDepartmentMed-OphthalmologyAll Tech InnovatorsHiroshi IshikawaJongsick S. KimJoel Steven SchumanDate Submitted2008-02-04
